Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2003245453 (hide)

Owner Merck & Co., Inc.

Inventors ARRINGTON, Kenneth, L.; Garbaccio, Robert M.; COLEMAN, Paul, J.; Fraley, Mark E.; Hoffman, William F.; TASBER, Edward, S.; Hartman, George D.; Cox, Christopher D.

Agent Spruson & Ferguson

Pub. Number AU-B-2003245453

PCT Number PCT/US03/18482

PCT Pub. Number WO2003/105855

Priority 60/458,318 28.03.03 US; 60/388,621 14.06.02 US; 60/426,940 15.11.02 US; 60/403,830 15.08.02 US

Filing date 12 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 14 August 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4045 (2006.01)

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4178 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4535 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 207/20 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

25 September 2003 Complete Application Filed

  Priority application(s): 60/458,318 28.03.03 US; 60/388,621 14.06.02 US; 60/426,940 15.11.02 US; 60/403,830 15.08.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003245453

14 August 2008 Application Accepted

  Published as AU-B-2003245453

11 December 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003245454-CHILD-RESISTANT DISPOSABLE LIGHTER

2003245452-METHOD OF MEASURING CHROMATED CONVERSION COATING AMOUNT USING INFRARED ABSORBANCE